TP53 and cancer: Of the 4,453 reported germline mutations (n = 1,655 families) in The TP53 Database (R20, July 2019 version; https://tp53.isb-cgc.org/), p.R337H was observed in 305 individuals (n = 117 families) representing 240 patients with cancer and 65 carriers unaffected by cancer.